 |
|
|
|
Timing: 09.30-10.30, Tuesday 19 June 2001
|
Venue: Sheraton Park Lane Hotel, Park Lane, London
|
|
|
|
09:30
|
Chairman's Introduction
Dr Steven DeKosky, University of Pittsburgh, USA
|
|
|
|
09:35
|
Understanding the Dementia Continuum
Dr Rachelle Doody, Baylor College of Medicine, Houston, USA
- Overall incidence and prevalence of dementia
- Dementia as a disease spectrum
- Segmentation by diagnosis and contributors
- Issues in different diagnosis
|
|
|
|
09:50
|
The Challenges of Treating Mixed and Vascular Dementia
Dr Timo Erkinjuntti, Memory Disorders Clinic, Helsinki University Hospital
- The clinical course of mixed/vascular dementia
- The current treatment (or non-treatment) paradigm
- Case studies
|
|
|
|
10:05
|
Reminyl: First Data on Use in Mixed/Vascular Dementia
Dr Roger Bullock, Kingshill Research Center-Victoria Hospital, UK
- Rationale for and design of RJS-INT-6 trial
- Study results
- Implications for physicians, patients and families
|
|
|
|
10:20
|
Questions to the Panel
|
|
|
|
10:30
|
Chairman's Conclusions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
